This paper reviews sleep disturbances in patients with major depressive disorders and the effects of different classes of antidepressants on sleep. It is clear from the studies reviewed that not all antidepressants improve sleep, and, indeed, some worsen sleep disturbances in patients with depression. Whether sleep is improved or further disrupted is of high clinical significance, because persistent sleep problems elevate the risk of relapse, recurrence, or suicide, as well as the need for augmenting medications.
ArmitageR. Microarchitectural findings in sleep EEG in depression: Diagnostic implications. Biol Psychiatry1995;37:72–84.
2.
BergerMRiemannD. REM sleep in depression–an overview. J Sleep Res1993;2:211–23.
3.
ReynoldsCFIIIKupferDJ. Sleep research in affective illness: State of the art circa 1987. Sleep1987;10:199–215.
4.
ArmitageRHoffmannR. Sleep electrophysiology of major depressive disorders. Current Review of Mood and Anxiety Disorders1997;1:139–51.
5.
BencaRMObermeyerWHThistedRAGillinJC. Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry1992;49:651–68.
6.
ThaseME. Is there a biological boundary to psychotherapy response in depression? Psychiatry Grand Rounds Presentation; March 27, 1998; the University of Texas Southwestern Medical Center, Dallas.
7.
FawcettJScheftnerWAFoggLClarkDCYoungMA, Hedeker D, and others. Time-related predictors of suicide in major affective disorder. Am J Psychiatry1990;147:1189–94.
8.
FordDEKamerowDB. Epidemiologic study of sleep disturbances and psychiatric disorders. JAMA1989;262:1479–84.
9.
WingardDLBerkmanLF. Mortality risk associated with sleeping patterns among adults. Sleep1983;6:102–7.
10.
RushAJGilesDERoffwargHPParkerCR. Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders. Biol Psychiatry1982;17:327–40.
11.
RushAJErmanMKGilesDESchlesserMACarpenterG, Vasavada N, and others. Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry1986;43:878–84.
12.
FrankEKupferDJHamerTGrochocinskiVJMcEachranAB. Maintenance treatment and psychobiologic correlates of endogenous subtypes. J Affect Disord1992;25:181–90.
13.
ThaseMEReynoldsCFIIIFrankEJenningsJRNofzingerE, Fasiczka AL, and others. Polysomnographic studies of unmedicated depressed men before and after cognitive behavioural therapy. Am J Psychiatry1994;151:1615–22.
14.
KupferDJFrankEMcEachranABGrochocinskiVJ. Delta sleep ratio: A biological correlate of early recurrence in unipolar affective disorder. Arch Gen Psychiatry1990;47:1100–5.
15.
BuysseDJKupferDJFrankEMonkTHRitenourA. Do electroencephalographic sleep studies predict recurrence in depressed patients successfully treated with psychotherapy?Depression1994;2:105–8.
16.
ArmitageRSussmanN. Effects of fluoxetine on sleep architecture and quality of sleep in depressed patients. Primary Psychiatry1997;4:34–7.
17.
VogelGWBuffensteinAMinterKHennesseyA. Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev1990;14:49–63.
18.
ArmitageR. Effects of antidepressant treatment on sleep EEG in depression. J Psychopharmacol1996;10:22–5.
19.
ArmitageRRushAJTrivediMCainJRoffwargHP. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology1994;10:123–7.
20.
VogelGCohenJMullisDKenslerTKaplitaS. Nefazodone and REM sleep: How do antidepressant drugs decrease REM sleep?Sleep1998;21:70–7.
21.
FeuilladePPringueyDBelugouJLRobertPDarcourtG. Trimipramine: Acute and lasting effects on sleep in healthy and major depressive subjects. J Affect Disord1992;24:135–45.
22.
SonntagARotheBGuldnerJYassouridisAHolsboerFSteigerA. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression1996;4:1–13.
23.
WareJCBrownFWMooradPJJPittardJTCobertB. Effects on sleep: A double-blind study comparing trimipramine to imipramine in depressed insomniac patients. Sleep1989;12:537–49.
24.
WiegandMBergerMZulleyJvon ZerssenD. The effect of trimipramine on sleep in patients with major depressive disorder. Pharmacopsychiatry1986;19:198–9.
25.
DunleavyDLBrezinovaVOswaldIMacLeanAWTinkerM. Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Br J Psychiatry1972;120:663–72.
26.
KupferDJEhlersCLPollockBGNathanSPerelJM. Clomipramine and EEG sleep in depression. Psychiatry Res1989;30:165–80.
27.
KupferDJPerelJMPollockBGNathanRSGrochocinskiVJ, Wilson MJ, and others. Fluvoxamine versus desipramine: Comparative polysomnographic effects. Biol Psychiatry1991;29:23–40.
28.
ShipleyJEKupferDJDealyRSGriffinSJCoblePA, McEachran AB, and others. Differential effects of amitriptyline and of zimelidine on the sleep electroencephalogram of depressed patients. Clin Pharmacol Ther1984;36:251–9.
29.
ShipleyJEKupferDJGriffinSJDealyRSCoblePA, McEachran AB, and others. Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients. Psychopharmacology1985;85:14–22.
30.
SharpleyALCowenPJ. Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry1995;37:85–98.
31.
KupferDJFosterFGReichLThompsonKSWeissR. EEG sleep changes in REM sleep and clinical depression. Am J Psychiatry1976;133:622–6.
32.
GillinJCWyattRFFramDSnyderF. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology1978;59:267–72.
33.
HochliDRiemannDZulleyJBergerM. Initial REM sleep suppression by clomipramine: A prognostic tool for treatment response in patients with a major depressive disorder. Biol Psychiatry1986;21:1217–20.
34.
DunleavyDLFOswaldI. Phenelzine, mood response, and sleep. Arch Gen Psychiatry1973;28:353–6.
35.
KupferDJBowersMB. REM sleep and monoamine oxidase inhibition. Psychopharmacologia1972;27:183–90.
36.
MontiJM. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients. Br J Psychiatry1989;155:61–5.
37.
MinotRLuthringerRMacherJP. Effect of moclobemide on the psychophysiology of sleep/wake cycles: A neuroelectrophysiological study of depressed patients administered with moclobemide. Int J Clin Psychopharmacol1993;7:181–9.
38.
BurkeMJPreskomSH. Short-term treatment of mood disorders with standard antidepressants. In: BloomFEKupferDJ, editors. Psychopharmacology: The fourth generation of progress. New York: Raven Press, Ltd.; 1995. p 1053–65.
39.
ArmitageRYonkersKColeDRushAJ. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol1997;17:161–8.
40.
GillinJCRapaportMErmanMKWinokurAAlbalaBJ. A comparison of nefazodone and fluoxetine on mood and an objective, subjective, and clinician-rated measures of sleep in depressed patients: A double-blind, 8-week clinical trial. J Clin Psychiatry1997;58:185–92.
41.
HendrickseWARoffwargHPGrannemannBDOrsulakPJArmitageR, Cain JW, and others. The effects of fluoxetine on the polysomnogram of depressed outpatients: A pilot study. Neuropsychopharmacology1994;10:85–91.
42.
KeckPEJrHudsonJIDorseyCMCampbellPI. Effect of fluoxetine on sleep [letter]. Biol Psychiatry1991;29:618–9.
43.
KerkhofsMRielaertCde MaertelaerVLinkowskiPCzarkaMMendlewiczJ. Fluoxetine in major depression: Efficacy, safety and effects on sleep polygraphic variables. Int J Clin Psychopharmacol1990;5:253–60.
44.
RushAJArmitageRGillinJCYonkersKAWinokurA, Moldofsky H, and others. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry1998;44:3–14.
45.
ArmitageREmslieGRintelmannJ. The effect of fluoxetine on sleep EEG in childhood depression: A preliminary report. Neuropsychopharmacology1997;17:241–5.
46.
TrivediMHRushAJArmitageRGullionCMGrannemannBD, Orsulak PJ, and others. Effects of fluoxetine on the polysomnogram in outpatients with major depression. Neuropsychopharmacology1999;20:447–59.
47.
BuysseDJKupferDJCherryCStapfDFrankE. Effects of prior fluoxetine treatment on EEG sleep in women with recurrent depression. Neuropsychopharmacology1999;21:258–67.
48.
ArmitageRTrivediMRushAJ. Fluoxetine and oculomotor activity during sleep in depressed patients. Neuropsychopharmacology1995;12:159–65.
49.
DorseyCMLukasSECunninghamSL. Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology1996;14:437–42.
50.
SchenckCHMahowaldMWKimSWO'ConnorKAHurwitzTD. Prominent eye movements during NREM sleep and REM sleep behaviour disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep1992;15:226–35.
51.
RothT. Diagnosis and treatment of sleep disorders in the depressed elderly [abstract]. Presented at the American Psychiatric Association 150th Annual Meeting Industry Supported Symposium 23 – Depression in the Elderly; May 17–22, 1997; San Diego, CA.
52.
EllisonJMStanzianiP. SSRI-associated nocturnal bruxism in four patients. J Clin Psychiatry1993;54:432–4.
53.
RomanelliFAdlerDABungayKM. Possible paroxetine-induced bruxism. Ann Pharmacother1996;30:1246–8.
54.
StanerL.KerkhofsM.DetrouxD.LeymanS.LinkowskiP.MendlewiczJ. Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: A double-blind randomized trial in major depression. Sleep1995;18:470–7.
55.
NowellPDReynoldsCFIIIBuysseDJDewMAKupferDJ. Paroxetine in the treatment of primary insomnia: Preliminary clinical and electroencephalogram sleep data. J Clin Psychiatry1999;60(2):89–95.
56.
GreenTDReynoldsCFIIIMulsantBHPollockBGMillerMD, Houck PR, and others. Accelerating antidepressant response in geriatric depression: A post hoc comparison of combined sleep deprivation and paroxetine versus monotherapy with paroxetine, nortriptyline, or placebo. J Geriatr Psychiatry Neurol1999;12(2):67–71.
57.
WinokurASewitchDEBimaurIVPhilipsJL. Effects of sertraline on sleep architecture in patients with major depression. Clin Neuropharmacol1992;(Suppl 1):84.
58.
BergerMEmrichHMLundDRiemannDLauerC. Sleep-EEG variables as course criteria and predictors of antidepressant therapy with fluvoxamine/oxaprotiline. Advanced Pharmacotherapy1986;2:110–20.
59.
KupferDJFosterGFReidLThompsonKSWeissB. EEG sleep changes as predictors in depression. Am J Psychiatry1987;133:622–6.
60.
van BemmelALvan den HoofdakkerRHDgemBeersmaBouhuysAL. Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology1993;113:225–30.
61.
MouretJLemoinePMinuitMPBenkelfatCRenardetM. Effects of trazodone on the sleep of depressed subjects – a polysomnographic study. Psychopharmacology1988;95:37S–43S.
62.
ScharfMBSachaisBA. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J Clin Psychiatry1990;51:13–7.
63.
van BemmelALHavermansRBvan DiestR. Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology1992;107:569–74.
64.
JacobsenFM. Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: A pilot study. J Clin Psychiatry1990;51:298–302.
65.
NierenbergAAKeckPEJr., Management of monoamine oxidase inhibitor-associated insomnia with trazodone. J Clin Psychopharmacol1989;9:42–5.
66.
ZimmerBDalyFBenjaminL. More on combination antidepressant therapy. Arch Gen Psychiatry1984;41:527–8.
67.
HaffmansPMVosMS. The effects of trazodone on sleep disturbances induced by brofaromine. European Psychiatry, 1999;14(3):167–71.
68.
SharpleyALWalshAESCowenPJ. Nefazodone - a novel antidepressant - may increase REM sleep. Biol Psychiatry1992;31:1070–3.
69.
ScharfMBMcDannoldMZaretskyNSpinnerOStoverR, Berkowitz DV, and others. Evaluation of sleep architecture and cyclic alternating pattern rates in depressed insomniac patients treated with nefazodone hydrochloride. American Journal of Therapeutics1999;6(2):77–82.
70.
ThaseMD. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry1999;60(Suppl 17):28–31(discussion)46–8.
71.
CarpenterLLJocicZHallJMRasmussenSAPriceLH. Mirtazapine augmentation in the treatment of refractory depression. J Clin Psychiatry1999;60(1):45–9.
72.
GillinJCSohnJ-WStahlSMLardonMKelsoeJ, Rapaport M, and others. Ipsapirone, a 5-HT1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls. Neuropsychopharmacology1996;15:109–15.
73.
BessettABrissaudESenegasEBilliardM. Effects of buspirone on night sleep architecture and daytime performances. Sleep Research1987;16:75.
74.
BrownMDriverH, Luus H, and others. Ipsapirone: Its effects on sleep and nocturnal temperatures of normal subjects. Sleep Research1991;20A:120.
75.
CooperBRWangCMCoxRFNortonRSheaVFerrisRM. Evidence that the acute behavioural and electrophysiological effects of bupropion (Wellbutrin?) are mediated by a noradrenergic mechanism. Neuropsychopharmacology1994;11:133–41.
76.
NofzingerEAReynoldsCFIIIThaseMEFrankEJenningsJR, Fasiczka AL, and others. REM sleep enhancement by bupropion in depressed men. Am J Psychiatry, 1995;152:274–6.
77.
MendlewiczJDunbarGCHoffmanG. Changes in sleep EEG architecture during the treatment of depressed patients with mianserin. Acta Psychiatr Scand1985;72:26–9.
78.
ArmitageRTrivediMHoffmannRRushAJ. Relationship between objective and subjective sleep measures in depressed patients and healthy controls. Depression and Anxiety1997;5:97–102.
79.
YonkersKAKandoJCColeJOBlumenthalS. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry1992;149:587–95.
80.
HoffmannRFArmitageRTrivediMHRushAJ. The effects of fluoxetine on quantitative sleep EEG in depressed outpatients. Sleep and Hypnosis1999;1:217–24.
81.
LianJ. Nefazodone treatment of depression requires less use of concomitant anxiolytic and sedative/hypnotic drugs. Paper presented at the Annual Meeting of the American Psychiatric Association; May 17–22, 1997; San Diego, CA: APA New Research Program and Abstracts (Vol NR397); 1997. p 175.
82.
RickelsKSchweizerECaseWGDeMartinisNGreenblattDJ, Mandos LA, and others. Nefazodone in major depression: Adjunctive benzodiazepine therapy and tolerability. J Clin Psychopharmacol1998;18(2):145–53.
